Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-02

Clinical Trial Update: Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy

View source ↗

Summary

This ClinicalTrials.gov update describes a study assessing changes in myocardial perfusion after optimal medical therapy in symptomatic hypertrophic obstructive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Vienna | Conditions: Hypertrophic Obstructive Cardiomyopathy \(HOCM\) | Status: RECRUITING